Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Journal of Magnetic Resonance Imaging : JMRI
|
June 19, 2024
Enhancing Tumor Microstructural Quantification With Machine Learning and Diffusion-Relaxation MRI
Carlos Macarro, Kinga Bernatowicz, Alonso Garcia-Ruiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2019
Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria
Ignacio Matos, Juan Martin-Liberal, Alonso García-Ruiz, et al.
Communications Medicine
|
November 20, 2025
Clinically feasible liver tumour cell size measurement through histology-informed in vivo diffusion MRI
Francesco Grussu, Athanasios Grigoriou, Kinga Bernatowicz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2025
Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterations
Marie Morfouace, Franck Bielle, Evangelia Razis, et al.
Communications Biology
|
November 26, 2025
Histology-informed microstructural diffusion simulations for MRI cancer characterisation-the Histo-μSim framework
Athanasios Grigoriou, Carlos Macarro, Marco Palombo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer
Timothy A Yap, Maria Vieito, Capucine Baldini, et al.
Neuro-Oncology Advances
|
November 16, 2022
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
Maria Vieito, Matteo Simonelli, Filip de Vos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 13, 2021
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Ignacio Matos, Guillermo Villacampa, Cinta Hierro, et al.
NPJ Precision Oncology
|
January 6, 2026
Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study
Oriol Mirallas, Fiorella Ruiz-Pace, Gabriel Velilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With <i>BRAF</i> V600-Mutant Solid Tumors
Maria Vieito, Elisa Fontana, Catherine H Han, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Journal of Magnetic Resonance Imaging : JMRI
|
June 19, 2024
Enhancing Tumor Microstructural Quantification With Machine Learning and Diffusion-Relaxation MRI
Carlos Macarro, Kinga Bernatowicz, Alonso Garcia-Ruiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2019
Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria
Ignacio Matos, Juan Martin-Liberal, Alonso García-Ruiz, et al.
Communications Medicine
|
November 20, 2025
Clinically feasible liver tumour cell size measurement through histology-informed in vivo diffusion MRI
Francesco Grussu, Athanasios Grigoriou, Kinga Bernatowicz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2025
Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterations
Marie Morfouace, Franck Bielle, Evangelia Razis, et al.
Communications Biology
|
November 26, 2025
Histology-informed microstructural diffusion simulations for MRI cancer characterisation-the Histo-μSim framework
Athanasios Grigoriou, Carlos Macarro, Marco Palombo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer
Timothy A Yap, Maria Vieito, Capucine Baldini, et al.
Neuro-Oncology Advances
|
November 16, 2022
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
Maria Vieito, Matteo Simonelli, Filip de Vos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 13, 2021
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Ignacio Matos, Guillermo Villacampa, Cinta Hierro, et al.
NPJ Precision Oncology
|
January 6, 2026
Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study
Oriol Mirallas, Fiorella Ruiz-Pace, Gabriel Velilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With <i>BRAF</i> V600-Mutant Solid Tumors
Maria Vieito, Elisa Fontana, Catherine H Han, et al.
Page
of 4